FLSM
Frazier Life Sciences Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120M | Buy |
12,466,489
+2,357,210
| +23% | +$22.6M | 4.78% | 6 |
|
|
2025
Q1 | $63.4M | Hold |
10,109,279
| – | – | 2.9% | 10 |
|
|
2024
Q4 | $82.1M | Hold |
10,109,279
| – | – | 3.41% | 11 |
|
|
2024
Q3 | $183M | Hold |
10,109,279
| – | – | 7.33% | 3 |
|
|
2024
Q2 | $104M | Hold |
10,109,279
| – | – | 4.87% | 5 |
|
|
2024
Q1 | $107M | Hold |
10,109,279
| – | – | 4.53% | 6 |
|
|
2023
Q4 | $92.3M | Hold |
10,109,279
| – | – | 4.93% | 7 |
|
|
2023
Q3 | $105M | Hold |
10,109,279
| – | – | 6.96% | 5 |
|
|
2023
Q2 | $145M | Buy |
10,109,279
+1,702,127
| +20% | +$24.4M | 8.65% | 3 |
|
|
2023
Q1 | $60M | Hold |
8,407,152
| – | – | 4.35% | 8 |
|
|
2022
Q4 | $94.3M | Hold |
8,407,152
| – | – | 5.86% | 7 |
|
|
2022
Q3 | $93.2M | Buy |
8,407,152
+2,579,737
| +44% | +$28.6M | 7.17% | 3 |
|
|
2022
Q2 | $49.2M | Hold |
5,827,415
| – | – | 4.64% | 7 |
|
|
2022
Q1 | $79.3M | Buy |
+5,827,415
| New | +$79.3M | 6.76% | 2 |
|